Immunohistochemical analysis demonstrated that NSUN2 was slightly increased in intrinsic gefitinib-resistant NSCLC patients compared to gefitinib-sensitive patients (Figure S1a). The gene discussed is NSUN2; the disease is non-small cell lung carcinoma.